SynAct Pharma AB (STO:SYNACT)

SynAct Pharma AB Balance Sheet

Financials in millions SEK. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	51.16	61.21	62.4	108.25	24	14.55
Cash & Short-Term Investments	51.16	61.21	62.4	108.25	24	14.55
Cash Growth	-0.76%	-1.90%	-42.36%	351.08%	64.95%	315.06%
Other Receivables	15.41	14.43	12.41	14.7	10.67	6.46
Receivables	15.41	14.43	12.41	14.7	10.67	6.46
Prepaid Expenses	6.24	18.37	0.26	17.29	0.25	0.32
Other Current Assets	-	-0	-0	-0	0	-
Total Current Assets	72.81	94	75.06	140.23	34.92	21.33
Property, Plant & Equipment	1.68	1.94	0.66	2.1	3.18	-
Long-Term Investments	-	0.05	0.14	0.27	0.27	0.26
Long-Term Deferred Charges	144.54	154.59	152.16	-	-	-
Other Long-Term Assets	0.14	19.94	0	-	-	-
Total Assets	219.17	270.52	228.02	142.6	38.37	21.59
Accounts Payable	2.07	17.35	9.67	4.72	4.25	2.78
Accrued Expenses	8.21	10.09	9.82	4.91	7.89	2.76
Current Portion of Leases	0.58	0.6	0.58	1	0.98	-
Other Current Liabilities	0.42	0.42	4.88	4.38	2.27	0.19
Total Current Liabilities	11.27	28.46	24.94	15.01	15.39	5.73
Long-Term Leases	1.07	1.29	0.06	1.06	2.11	-
Long-Term Deferred Tax Liabilities	17.11	18.3	18.02	-	-	-
Other Long-Term Liabilities	8.59	8.3	8.82	-	-	-
Total Liabilities	38.04	56.35	51.83	16.08	17.5	5.73
Common Stock	6.13	5.81	4.45	3.71	3.25	3.05
Additional Paid-In Capital	763.55	762.8	646.57	394.84	193.6	119.4
Retained Earnings	-597.69	-573	-490.6	-274.79	-175.59	-106.28
Comprehensive Income & Other	9.15	18.56	15.77	2.77	-0.4	-0.3
Shareholders' Equity	181.14	214.17	176.19	126.52	20.87	15.87
Total Liabilities & Equity	219.17	270.52	228.02	142.6	38.37	21.59
Total Debt	1.64	1.88	0.64	2.06	3.09	-
Net Cash (Debt)	49.52	59.33	61.76	106.18	20.91	14.55
Net Cash Growth	-3.01%	-3.94%	-41.84%	407.85%	43.72%	315.06%
Net Cash Per Share	1.15	1.50	1.90	3.85	0.81	0.68
Filing Date Shares Outstanding	49.01	46.49	35.57	31.82	26.01	24.41
Total Common Shares Outstanding	49.01	46.49	35.57	29.65	26.01	24.41
Working Capital	61.54	65.54	50.12	125.22	19.53	15.6
Book Value Per Share	3.70	4.61	4.95	4.27	0.80	0.65
Tangible Book Value	181.14	214.17	176.19	126.52	20.87	15.87
Tangible Book Value Per Share	3.70	4.61	4.95	4.27	0.80	0.65

Source: S&P Global Market Intelligence. Standard template. Financial Sources.